Merck news

Opko Health Finalizes Purchase of NK-1 Compounds from Schering

Trading Markets - 30 minutes ago
Nov 17, 2009 (Close-Up Media via COMTEX) -- OPK -- Opko Health, Inc. has announced that it has completed the acquisition of rolapitant and a related compound from Schering Corp., a subsidiary of ...

Beazer, Merck, Citigroup, Lowe's are big movers

The Associated Press - 52 minutes ago
NEW YORK — The following stocks were among those that moved substantially or traded heavily Monday on the New York Stock Exchange: NYSE: Beazer Homes USA Inc., down 35 cents at $5.14 ...

52-Week High Club (FDX, LNY, MRK, GOOG)

24/7 Wall St. - 51 minutes ago
FedEX Corp. (NYSE: FDX) over 3% to a yearly high of $84.92. Barron's reported that the package delivery company may rise as high as $100 dollars according to a survey of investors and analysts ...

International Healthcare Stock Winners From Natcan Investment Management

The Wall Street Transcript - 1 hour ago
November 16, 2009 - The Wall Street Transcript has just published Biotechnology Report offering a timely review of the Biotechnology sector. This Special Report contains expert industry commentary ...

2009年11月16日星期一21:27 BJT

路透社 - 34 minutes ago
By Bill Berkrot and Ransdell Pierson ORLANDO, Nov 15 (Reuters) - Abbott Laboratories' (ABT.N: 行情) Niaspan appeared to be more effective and safer than Merck & Co's (MRK.N: 行情) Zetia as a ...

UPDATE 1-Merck up as Zetia trial less damaging than feared

Positive Drug Study Pushes Merck (MRK) To New Highs, See What What We Found Out

Market Intelligence Center - 10 minutes ago
Merck (NYSE: MRK) hit a new 52-Week high of $34.35 so far today. Currently the stock is up $1.16 (3.5%) to $34.26 on 10,302,861 shares traded. Today's high is up $14.21 from a 52-Week Low of $20 ...

Family values pay off for Merck

Wealth Bulletin - 16 minutes ago
He is not yet two years old but already Thomas, the first member of the 13th generation of his family, is being initiated into the working of the family business – Merck, the world's oldest ...

BUSINESS WIRE: Erbitux Recognized by ASCO as a 2009 Major Cancer Advance as First SCCHN

STOCKS NEWS US-Abbott drug seen safer than Merck's Zetia

Interactive Investor - 3 minutes ago
Abbott Laboratories' Niaspan appeared to be more effective and safer than Merck & Co's Zetia as a supplementary cholesterol treatment to statins, according to a small study that is likely to ...